HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Perrigo

This article was originally published in The Rose Sheet

Executive Summary

Perrigo: Private-label company second quarter FY 1996 (ended Dec. 31) consolidated sales rose 15% to $201 mil. over the prior year period. The increase was driven by the acquisition of Vi-Jon Labs for $35 mil. in January 1994, according to Perrigo ("The Rose Sheet" Dec. 12, 1994 In Brief). Sales were slightly higher in the personal care segment, with a 17% increase in the quarter, the company said. Overall Perrigo net income was down 5.4% to $12.2 mil. compared to a year ago. For the six months, net sales rose 13.6% to $406.1 mil. while Perrigo's personal care business revenues increased 19%. Net income for the half dropped 11.8% to $24.4 mil. compared 1995. Separately, previous plans to consolidate Perrigo's three distribution centers into the Atlanta location by March ("The Rose Sheet" July 3, p. 9) have been delayed until FY 1997, the company said...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS002511

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel